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The small membrane protein p7 of hepatitis C virus forms 
oligomers and exhibits ion channel activity essential for virus 
infectivity. These viroporin features render p7 an attractive tar­
get for antiviral drug development. In this study, p7 from strain 
HCV-J (genotype f b) was chemically synthesized and purified 
for ion channel activity measurements and structure analyses. 
p7 forms cation-selective ion channels in planar lipid bilayers 
and at the single-channel level by the patch clamp technique. 
Ion channel activity was shown to be inhibited by hexamethyl­
ene amiloride but not by amantadine. Circular dichroism anal­
yses revealed that the structure of p7 is mainly a-helical, irre­
spective of the membrane mimetic medium (e.g. lysolipids, 
detergents, or organic solvent/water mixtures). The secondary 
structure elements of the monomeric form of p7 were deter­
mined by 1H and 13C NMR in trifluoroethanol/water mixtures. 
Molecular dynamics simulations in a model membrane were 
combined synergistically with structural data obtained from 
NMR experiments. This approach allowed us to determine the 
secondary structure elements of p7, which significantly differ 
from predictions, and to propose a three-dimensional model of 
the monomeric form of p7 associated with the phospholipid 
bilayer. These studies revealed the presence of a turn connecting 
an unexpected N-terminal a-helix to the first transmembrane 
helix, TMf, and a long cytosolic loop bearing the dibasic motif 
and connecting TMf to TM2. These results provide the first 
detailed experimental structural framework for a better under­
standing of p7 processing, oligomerization, and ion channel gat­
ing mechanism.
Hepatitis C virus (HCV)8 infection is a major cause of human 
chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma 
(1). About 170 million individuals worldwide are chronically 
infected with HCV, and current therapy based on a combina­
tion of pegylated interferon and ribavirin is poorly tolerated and 
ineffective in 50% of patients. In this context, the ongoing 
search for new drugs and targets is very active, and the struc­
tural and functional characterization of the HCV viroporin p7 
is essential for the molecular understanding of its role in HCV 
replication and for antiviral drug development.
HCV is a highly variable enveloped positive-stranded RNA 
virus, and patient isolates are classified into seven genotypes 
and numerous subtypes (2, 3) within the genus Hepacivirus of 
the family Flaviviridae (4). The HCV genome encodes a 
polyprotein precursor, NH2-C-El-E2-p7-NS2-NS3-NS4A- 
NS4B-NS5A-NS5B-COOH, of about 3,000 amino acids that is 
co- and post-translationally processed by cellular and viral pro­
teases to yield 10 mature viral proteins. The latter include the 
structural proteins (C, El, and E2) that constitute the viral par­
ticle; p7 and NS2, required for virus assembly; and NS3 to NS5B 
involved in HCV replication (reviewed in Ref. 5).
p7 is often incompletely cleaved from E2 (6), but it is likely to 
be a non-structural protein (7). p7 is found primarily in the 
endoplasmic reticulum as an integral membrane protein and 
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displays a topology in which both N and C termini point toward 
the endoplasmic reticulum lumen (8). However, an alternative 
topology wherein the C terminus is exposed to the cytoplasm 
may be adopted (9). p7 is not required for RNA replication in 
vitro but is essential for the late phase of assembly and the 
release of infectious HCV in vitro (7, 10) as well as productive 
infection in vivo (11). p7 probably acts in concert with other 
viral structural proteins (core, El, and E2) and/or NS2, and its 
function may depend on interactions with other viral factors, 
such as core and/or NS2 (12-14).
p7 is a hydrophobic, 63-amino acid polypeptide comprising 
two predicted transmembrane a-helices connected by a short 
polar loop, including a conserved dibasic motif (7, 8, 15). Pre­
liminary solid-state NMR analyses of recombinant p7 reconsti­
tuted in a phospholipid environment confirmed that p7 con­
tains helical segments, which are slightly tilted relative to the 
membrane bilayer (16). p7 belongs to the family of viroporins, 
which contains small virally encoded membrane proteins, 
including M2 of the influenza virus and vpu of the human 
immunodeficiency virus HIV-1 (17). These polypeptides 
modify the membrane cell permeability to ions and small mol­
ecules. Isolated p7 reconstituted in artificial membranes has 
been reported to form oligomers and to possess cation channel 
activity, which is inhibited by long alkyl chain imino-sugar 
derivatives (18), amiloride compounds (19), and amantadine 
(20), albeit the latter appeared to be genotype-dependent (21, 
22). Nevertheless, the relationship between the ion channel 
activity and the role of p7 in assembly and release of infectious 
HCV particles in cell culture is not known.
Electron microscopy studies revealed that p7 monomers 
could assemble into hexamers (20, 23) or heptamers (24) in 
artificial membranes. Single-particle electron microscopy 
recently allowed the three-dimensional structure of the hexam­
eric p7 ion channel to be determined at 16 A resolution, reveal­
ing a flower-shaped protein architecture with six protruding 
petals oriented toward the endoplasmic reticulum lumen (23). 
However, no detailed structure of p7 monomers has been 
reported hitherto, and currently proposed p7 models are based 
on secondary structure predictions (23-26). Electrophysiology 
experiments indicate that the predicted N-terminal helix lines 
the p7 oligomer pore (27, 28), a finding consistent with pro­
posed p7 oligomer models.
In the present study, we report the ion channel activity of 
chemically synthesized p7 reconstituted in artificial mem­
branes. Moreover, we combined NMR analyses and molecular 
dynamics simulations in a palmitoyloleyl-phosphatidylcholine 
(POPC) lipid bilayer to put forth the first detailed structure of 
the monomeric p7 embedded in a lipid membrane. Examina­
tion of this structure model in combination with analysis of 
conservation and variability of p7 amino acids among repre­
sentative HCV genotypes allowed us to highlight the essential 
structural features of p7, which are determinants of the ion 
channel gating mechanism or may be associated with its role in 
facilitating HCV particle assembly and release from infected 
cells. The p7 monomer model reported here provides an exper­
imental template for further investigations of the p7 ion chan­
nel gating mechanism and for the development of antiviral 
drugs.
EXPERIMENTAL PROCEDURES
Sequence Analyses—Sequence analyses were performed 
using tools available at the Instituí de Biologie et Chimie des 
Protéines (IBCP) (z.e. the Network Protein Sequence Analysis 
(NPSA) Web site) (29). Provisional and confirmed genotyped 
HCV p7 sequences were retrieved from the European HCV 
Database (3). Multiple-sequence alignments were performed 
with ClustalW (30), using the default options.
Peptide Synthesis and Purification—The full-length p7 was 
synthesized chemically by solid-phase synthesis by Dr. G. 
Bloomberg at the Peptide Synthesis Unit of the Department of 
Biochemistry (University of Bristol, Bristol, UK). N-terminal 
and C-terminal p7 peptides 1-34 and 35-63 (denoted p7(l— 
34) and p7(35— 63), respectively)9 were synthesized by Clon­
estar Biotech s.r.o. (Brno, Czech Republic). The full-length p7, 
p7(l—34), and p7(35— 63) peptides were purified by reversed- 
phase HPLC on a Vydac C8 column (300 A, 10 /tin, 10 X 250 
mm) using a water/acetonitrile gradient containing 0.1% triflu­
oroacetic acid (31), and their molecular masses were confirmed 
by mass spectrometry. The purity of the full-length p7 and 
p7(35— 63) peptides (>98%) was checked by reversed-phase 
HPLC, mass spectrometry, and NMR spectroscopy.
9 For consistency with standard protein chemistry nomenclature, the p7 
peptide 35-63 will be referred to as p7(35-63),and residues within this 
peptide will be numbered from the start of the p7 protein and corre­
sponding to HCV polyprotein residues 747-809 of strain HCV-J, geno­
type 1 b (GenBank™ accession number D90208).
Planar Lipid Bilayer Assay—Virtually solvent-free planar 
lipid bilayers were formed as described (31, 32) over a 100- 
150-p.m hole in a polytetrafluoroethylene film (10 /tin thick) 
pretreated with a mixture of 1:40 (v/v) hexadecane/hexane and 
sandwiched between two half glass cells. Phosphatidylcholine 
from soy beans (asolectin from Sigma type IV S), dissolved in 
hexane (0.5%) was spread on the top of electrolyte solution (500 
mM KC1,10 mM HEPES, pH 7.4) in both compartments. Bilayer 
formation was achieved by lowering down and raising up the 
level in one or both compartments and monitoring capacity 
responses. Voltage was applied through an Ag/AgCl electrode 
in the czs-side, and the trans-side was grounded. The purified 
peptides dissolved in 1% DM were added in the concentration 
range 5X10 9 to 5 X 10 R m. The peptide-containing mem­
branes were subjected to slow ramps of potential (10 mV/s), 
and transmembrane currents were fed into an amplifier (BBA- 
01, Eastern Scientific (Rockville, MD)). Current-voltage curves 
were stored on a computer and analyzed with the Scope soft­
ware (Bio-logic, Claix, France). For ion selectivity measure­
ments, zero current potentials were determined by establishing 
a 10-fold KC1 gradient (500 mM/50 mM cis!trans) across the 
bilayer. The ion selectivity was characterized by the ratio PJPa 
(i.e. the ratio of the permeability for cations and the permeabil­
ity for anions) calculated according to the Goldman-Hodgkin- 
Katz equation (33). All experiments were carried out at room 
temperature, and the bath solution of the cA-side compartment 
was stirred during the measurements.
Reconstitution of p7 into Liposomes and Patch Clamp 
Recordings—The purified p7 dissolved in 90% 2,2,2-trifluoro- 
ethanol (TFE) was mixed with asolectin in chloro form/metha­
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nol (1:1) (protein/lipid ratio of 1:500-1:5000 (w/w)) or 1% 
w-dodecyl /3-D-maltoside (10 /j,m p7 in 1% DM), dried under a 
nitrogen flux, and lyophilized to remove any trace of solvent 
and water. The lyophilized sample with asolectin was directly 
resuspended in 2 ml of 500 mM KC1,10 mM HEPES, pH 7.4, and 
sonicated in a bath sonicator until clarity. The resulting vesicle 
suspension was centrifuged for 20 min at 50,000 rpm at 4 °C. 
The lyophilized p7 sample in DM (10 p,M p7 in 1% DM) was 
incubated with asolectin vesicles at protein/lipid ratios of 
1:2000-1:5000 for 30 min at room temperature before removal 
of detergent by the addition of polystyrene beads (Bio-Beads 
SM-2 from Bio-Rad) at a concentration of 80 mg of Bio­
Beads/ ml of protein solution in 1 % DM. After 4 h, the Bio-Beads 
were discarded, and the suspension was centrifuged for 20 min 
at 50,000 rpm at 4 °C. The pellets were suspended in 30 /xl of 10 
mM HEPES (pH 7.4), and aliquots were subjected to a dehy- 
dratation/rehydratation procedure to obtain giant proteolipo- 
somes (31). For each experiment, 1-2 /j.1 of the rehydrated sus­
pension were placed in a 1-ml chamber containing the 
recording solution (500 mM KC1,10 mM HEPES, pH 7.4). Mem­
brane patches, obtained from unilamellar blisters from collaps­
ing liposomes, were examined using the standard patch clamp 
technique (34, 35). The micropipettes used were borosilicate 
glass capillaries (Harvard Apparatus, Kent, UK) filled with the 
recording solution. The single-channel currents were visual­
ized with the Visual Patch 500 amplifier (Bio-logic, Claix, 
France), and the recorded data were treated with Biotools soft­
ware (Bio-logic). For the ion channel inhibition tests, we used 
hexamethylene amiloride (HMA) purchased from Sigma and 
two lots of amantadine from Sigma and Fluka.
Analytical Centrifugation—'The samples were prepared 
from co-lyophilized p7 and C12E8 dissolved in a mixture of 
— 51% D20,49% H2O of density 1.05655 g/ml (z.e. the density 
of the detergent (36)) and viscosity 1.127 millipascal. The 
experiments were performed using a Beckman XL-I analyt­
ical ultracentrifuge and an AN-60 TI rotor (Beckman 
Coulter) in a 12-mm optical path length cell equipped with 
sapphire windows. Further details are provided in the leg­
ends of supplemental Fig. S2 and Table S2.
Circular Dichroism—Circular dichroism (CD) spectra were 
recorded on a Jobin Yvon CD6 spectrometer calibrated with 
(lS)-(+)-10-camphorsulfonic acid. The measurements were 
carried out at room temperature in a 0.1-cm path length quartz 
cuvette, with peptide concentrations ranging from 30 to 60 p,M. 
The spectra were recorded in the 190-250-nm wavelength 
range with a 0.2-nm increment and a 2-s integration time. They 
were subsequently processed with the CD6 software, base line- 
corrected, and smoothed by using a third-order least-squares 
polynomial fit. The spectral units were expressed as a molar 
ellipticity/residue by using peptide concentrations determined 
from measurements of UV light absorbance of tyrosine and 
tryptophan at 280 nm (molar extinction coefficients of 1,536 
and 5,600 M_1,cm_1, respectively). The secondary structure 
content was estimated with various deconvolution methods, 
employing the DICHROWEB server (37).
NMR Spectroscopy—The purified p7 andp7(35-63) peptides 
were dissolved either in 100 mM dodecylphosphocholine 
(DPC)-iZ38 (>98%) or SDS-iZ25 (>98%) or in mixtures of 
50-90% TFE-iZ2 (>99%) in H2O (v/v) at a final concentration of 
about 1.3 mM. 2,2-dimethyl-2-silapentane-5-sulfonate was 
added to the NMR samples as an internal XH chemical shift 
reference. The spectra were acquired at temperatures of 20 and 
25 °C. Multidimensional NMR experiments were performed on 
a Varian Unily-p/M.s' 500-MHz and a Varian Inova 800-MHz 
spectrometer equipped with triple-resonance 5-mm probes 
with a self-shielded z-gradienL coil. NOESY (mixing times 
between 100 and 250 ms), clean TOCSY (isotropic mixing time 
of 80 ms), and XH-X3C HSQC experiments were performed with 
conventional optimized pulse sequences, as was detailed previ­
ously (see Refs. 38-40 and references therein). The Varian 
VNMR software was used to process all data, and Sparky was 
used for spectral analysis (T. D. Goddard and D. G. Kneller, 
University of California San Francisco). The resonances of pro­
tons were ascribed by the conventional assignment method 
(41). In short, intraresidue backbone resonances and aliphatic 
side chains were identified from two-dimensional DQF-COSY 
and TOCSY spectra, with the help of XH-X3C HSQC and HSQC- 
TOCSY spectra in natural X3C abundance at 20 and 25 °C to 
resolve the overlap of resonances (42). Sequential assignments 
were determined by correlation of intraresidue assignments 
with interresidue cross-peaks observed in two-dimensional 
NOESY. NMR-derived XH a and X3Ca chemical shifts are 
reported relative to the random coil chemical shifts in TFE (43, 
44).
NMR-derived Distance Constraints and Structure Cal­
culation—NOE intensities used as distances input for structure 
calculations were obtained from the NOESY spectrum 
recorded with a 150-ms mixing time. NOEs were partitioned 
into three categories of intensities, which were converted into 
distances ranging from a common lower limit of 1.8 A to upper 
limits of 2.8, 3.9, and 5.0 A, respectively. The cross-peak inten­
sity of the H3-He protons of Tyr45 was used as the distance 
reference (2.45 A). Protons without stereospecific assignments 
were treated as pseudoatoms, and the correction factors were 
added to the upper distance constraints (41). Neither additional 
dihedral angle nor hydrogen bond restraints were introduced. 
The three-dimensional structures were generated from NOE 
distances by means of a dynamic simulated annealing protocol, 
using the XPLOR-NIH 2.0.7 program (45) and standard force 
field and default parameter sets. Sets of 50 structures were ini­
tially calculated to sample widely the conformational space, and 
the structures of low energy with no distance restraint viola­
tions (>0.5 A) were retained. The selected structures were 
compared by pairwise root mean square deviation over the 
backbone atom coordinates (N, Ca, and C'). Statistical analy­
ses, superimposition of structures, and structural analyses were 
performed with MOLMOL version 2.6 (46), AQUA version 3.2, 
and PROCHECK-NMR version 3.5.4 (47).
Molecular Modeling of the Monomeric HCV p7 Protein—On 
the basis of the structural information acquired from both CD 
experiments in membrane mimetics and NMR structures in 
TFE/water solutions, a model of the complete monomeric pro­
tein was built. Because the latter experiments only supply frag­
ments of the complete structure of p7 (see “Results”), a number 
of assumptions should be made when the segments of known 
structure are combined with those of undefined structure. The 
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p7 topology with both N and C termini pointing toward the 
endoplasmic reticulum lumen (8) indicates that the TM1 and 
TM2 a-helices probably form a hairpin motif that spans the 
entire hydrophobic core of the membrane. The construction of 
this motif, which implies the pairing of TM1 and TM2, was 
achieved by means of protein-protein molecular docking. Use 
was made of the GRAMM program (48) to explore a-helix asso­
ciation through rigid body translation and rotation of the indi­
vidual helical units. An optimized scoring function was 
employed, the target of which was membrane proteins. Explo­
ration was restrained to the formation of anti-parallel a-helix 
bundles. Among the solutions proposed by GRAMM, only 
those corresponding to strictly anti-parallel helical segments 
facing each other were retained. Selection was further nar­
rowed down by examination of the interhelical contacts and 
elimination of unphysical spatial arrangements. The two TM 
a-helices were subsequently bridged into a hairpin by means of 
a short, four-residue loop domain, by using the VMD program 
(49). The N-terminal a-helix was then pasted to the TM1 seg­
ment, before attachment of the unstructured C-terminal 
fragment at the tail end of the TM2 a-helix, thus completing 
the model of the protein. Backbone dihedral angles were 
checked against rotamer libraries and corrected whenever 
necessary. A rapid energy minimization was then performed, 
with the NAMD molecular dynamics program (50) with the 
CHARMM27 macromolecular force field (51) to remove 
spurious intramolecular contacts.
Molecular Dynamics Simulation—To appraise the relevance 
of the p7 protein model and shed new light on the subtle bal­
ance between protein-protein and protein-lipid interactions, 
the monomeric HCV p7 protein was finally immersed in a 
membrane environment. The latter consisted of a fully 
hydrated POPC lipid bilayer, which had been preliminarily 
thermalized. All simulations were performed in the isobaric- 
isothermal ensemble. The pressure and the temperature were 
maintained at 1 bar and 300 K, respectively, employing the 
Langevin piston algorithm (52) and softly damped Langevin 
dynamics. The particle mesh Ewald method (53) was utilized to 
compute electrostatic interactions. The r-RESPA multiple 
time-step integrator (54) was used with a time step of 2 fs for 
short range and 4 fs for long range forces. Covalent bonds involv­
ing a hydrogen atom were constrained to their equilibrium length. 
A 40-ns trajectory was generated, over which the last 20 ns were 
considered for the analysis of the molecular assembly.
RESULTS
Production ofp7—'["ne full-length 63-amino acid p7 polypep­
tide from strain HCV-J of genotype lb (accession number 
D90208; see Fig. GA) was obtained by chemical synthesis. To 
avoid any unexpected disulfide bond formation during CD and 
NMR experiments, cysteine 27 was replaced by an alanine (see 
sequence in Fig. 6A, mutC27A HCV-J). The choice of Ala 
instead of Ser for the mutation of Cys27 was motivated by the 
investigation of Griffin et al. (15), who reported that a C27A 
mutation results in only a slight reduction in p7 activity in a 
cell-based hemadsorption surrogate assay. In addition, no p7 
sequence variant incorporating a Ser at position 27 was ever 
reported among the 1325 sequences available to date in the 
HCV sequence databases (3). It should be noted, however, that 
Thr is observed in some variants, albeit only those of genotype 
2b. In contrast, one p7 sequence featuring an alanine at position 
27 was reported (accession number AY232730), and 1.7 and 
1.6% of the reported sequences include helix-stabilizing resi­
dues Vai and lie, respectively. Therefore, we expected that ala­
nine at position 27 would not disturb the predicted p7 helical 
folding in the corresponding region as well as the functionality 
of p7. The chemical synthesis of full-length p7 as well as syn­
theses of p7(l—34) and p7(35-63) were successful, yielding a 
crude product containing predominantly the expected peptide, 
as checked by electrospray mass spectroscopy. Further purifi­
cation by reversed-phase HPLC allowed us to prepare highly 
purified full-length p7 (>98%), albeit with a rather low yield 
(about 16%) (31). The p7(35— 63) peptide could also be highly 
purified by reversed-phase HPLC. In contrast, the p7(l—34) 
peptide appeared to be very difficult to purify and was only 
obtained in low amounts with about 85% purity.
p7 Ion Channel Properties—In order to check and investigate 
ion channel forming activity of the purified full-length p7 
C27A, the latter was first incorporated into planar lipid bilayers 
in the presence of symmetrical salt solutions. Current record­
ings in response to a triangular voltage ramp applied to an 
asolectin bilayer containing p7 are shown in Fig. 1A. These 
experiments performed in 500 mM KC1 solution revealed a non­
linear current-voltage curve, indicating that conductance char­
acteristics of p7 are a function of the membrane potential. 
Moreover, p7 showed a clearly asymmetric behavior in this cur­
rent-voltage diagram (i.e. it exhibits higher current values at 
negative voltages than at the corresponding positive voltages 
when added to one side of the planar lipid bilayer). It can also be 
observed from the current-voltage (I/V) curve that p7 channels 
remained open for a longer period at positive voltages than at 
the corresponding negative ones, as indicated by a broader hys­
teresis of the curve in the positive quadrant. It is noteworthy 
that this rectification is minimal when a larger amount of p7 
protein is incorporated into the planar lipid bilayer (see I/V 
curves in Fig. IB).
Measurements of ion selectivity were performed in a mul­
tichannel experiment by measuring the membrane potential 
developed by a salt gradient across the p7 channels at zero cur­
rent conditions (see supplemental Table SI). The potential 
obtained for a 10-fold KC1 gradient (500 mM KC1 in cis-side, 50 
mM KC1 in trans-side) was negative (i.e. the potential becomes 
negative on the side with the higher electrolyte solution, denot­
ing that p7 ion channel is cation-selective). The mean value of 
this potential corrected from the liquid junction potential was 
—41.0 ± 2.2 mV (average from four independent experiments) 
and resulted in a corresponding permeability ratio BK+/PC1- «= 
11 calculated by the Godlman-Hodgkin-Katz equation.
The channel activity of p7 was confirmed by examining iso­
lated membrane patches from proteoliposomes containing p7 
by the patch clamp technique. At a 1:5000 protein/lipid ratio, 
channel activity was observed in about 20 -30% of the liposome 
patches. As shown in Fig. 2A, this ion channel activity was 
found to be asymmetric according to the voltage polarity (i.e. 
the maximum value of current is larger at negative voltage). 
This asymmetric behavior, highly reproducible, as observed for
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FIGURE 1. Current-voltage relationship of p7 as measured by the 
response to a slow potential ramp of ± 150 mV to an asolectin bilayer. p7 
protein (5 nmol of 10/j.m p7 stock solution in 1% DM) was added to the cis side 
of the membrane bathed in 500 mM KCI, 10 mM HEPES, pH 7.4. The arrows 
indicate the direction of the applied voltage ramp. A, 1/V curve of p7. B, 1/V 
curve of p7 in the presence of HMA. Note that the 1/V curve in A shows a low 
rectification of the current and an asymmetric current (more current at neg­
ative potential). In the 1/V curve in B, the current is still asymmetric (always a 
larger current at negative potential), but the rectification is minimal. This is 
due to the fact that the amount of p7 protein incorporated into the bilayer is 
more important that in A.
measurements in planar lipid bilayers, indicated that p7 mole­
cules would insert in a preferred orientation into planar lipid 
bilayers as well as into liposomes. Current recordings obtained 
at positive voltages from liposome containing p7 showed better 
defined current fluctuations than those recorded at negative 
potentials. The major channel conductance values observed at 
+ 60 and +140 mV were 22 ± 6 and 41 ± 8 pS, respectively, in 
500 mM KCI, 10 mM HEPES, pH 7.4. At negative voltages, the 
conductance levels became less resolved, but an increase in sin­
gle-channel conductance values by a factor of —2-3.5 over the 
channels recorded at corresponding positive potentials could 
be detected. With liposomes containing a larger amount of p7 
(protein/lipid ratio, 1:500-1:2000), 50-60% of the patches 
were found to present a functional p7 protein. The current 
recordings obtained in these conditions resulted, however, in 
observation of multiple conductance level channels (marked 0, 
1, 2, and 3 in Fig. 2B). The conductance values 35, 57, 120, and 
184 pS observed in these conditions (500 mM KCI, 10 mM 
HEPES, pH 7.4) could represent the insertion of simultaneous 
channels, although we cannot exclude the possibility that level 3 
is a second conductance state of the channel with one more 
monomer in the conducting channel.
The p7 Ion Channel Activity Is Blocked by HMA but Not by 
Amantadine—It was previously reported that the p7 channel 
can be blocked by amantadine (20) and HMA (19). We indeed 
observed that the ion channel activity of our p7 peptide was 
inhibited by HMA in a concentration-dependent fashion (Fig. 
IB). The amplitude of the I/V curve of p7 without drug was 
reduced by about 40 -50% in the presence of 200 /j,m HMA. In a 
previous study, Premkumar et al. (19) reported an inhibition of 
the current with 100 p,M HMA through single channels of p7 of 
genotype la (strain H77). However, in accordance with our 
data, these authors mentioned that HMA did not completely 
block the channel activity with larger currents. In contrast, no 
inhibition by amantadine could be measured, regardless of the 
concentration used from 100 /j,m to 1 mM. Oddly enough, we 
observed that amantadine had a tendency to favor ion fluxes 
passing through p7 channels because the amplitudes of the I/V 
curves were increased after the addition of this drug (data not 
shown).
To determine which part of p7 was responsible for its ion 
channel activity, peptides p7(l—34) and p7(35—63), corre­
sponding to the N- and C-terminal half of p7, respectively, were 
synthesized. We found that the p7( 1—34) peptide solubilized in 
1% DM and reconstituted in planar lipid bilayers exhibited 
some ion channel activity. This segment displayed a heteroge­
neous channel activity with conductance values ranging from 
25 to 240 pS in 500 mM KCI, with a predominant well defined 
conductance state of about 60 pS (see supplemental Fig. SI). 
The limited purity of the p7(l—34) peptide, which appeared to 
be difficult to synthesize and to purify did not allow us to dem­
onstrate unambiguously that this peptide alone is responsible 
for the ion channel formation that we observed. This finding is, 
nonetheless, in agreement with that reported by Haqshenas et 
al. (27), who found that a peptide comprising the N-terminal 38 
residues of p7 could form ion channels. The p7(35— 63) seg­
ment was found to be totally insoluble in the conditions used 
above and could not be reconstituted in artificial lipid bilayers. 
This pronounced tendency toward aggregation, together with 
the strong overall hydrophobicity of the amino acid sequence, 
does not support the formation of ion channel via the C-termi­
nal half of p7.
Analytical Centrifugation ofp7 in Detergent C12E8—To char­
acterize the homogeneity and oligomerization state of p7 in 
detergent, p7 peptide (0.4 and 0.07 mg/ml) dissolved in C12E8 (2 
or 0.33 mg/ml) was studied by analytical ultracentrifugation in 
a mixture of 51% D2O and 49% H2O to match the density of this 
detergent (36). The sedimentation velocity revealed the pres­
ence of a main species together with some larger molecular 
weight species (see supplemental Fig. S2). Decreasing the deter­
gent concentration increased the relative amount of larger spe­
cies. The ratio of the fringe shift number obtained by interfer­
ence optics and absorbance at 280 nm allowed an estimate of 
12-16 molecules of C12E8 per p7 molecule (1-1.3 g/g). Assum­
ing an oligomeric state for p7 (see below), this value is consis­
tent with that reported for intrinsic membrane proteins (55). 
The range of the mean experimental sedimentation coefficients
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FIGURE 2. Single-channel recordings of p7 reconstituted into asolectin liposomes and examined by the 
patch clamp technique in 500 mM KCI, 10 mM HEPES, pH 7.4. >4, channel activity is shown at two positive 
pipette holding potentials and at their negative corresponding potentials. The base line (Bi) is shown as a 
horizontal line. The protein/lipid ratio is 1:5,000. An associated amplitude histogram is displayed to ther/'ghfof 
each recording. B, channel activity is shown at a pipette holding potential of + 140 mV. The protein/lipid ratio 
is 1:2,000. The numbers 0, 1, 2, and 3 represent the major conductance levels encountered in the selected 
recording, as illustrated in the associated amplitude histogram, ¿eve/0 corresponds to the closed state of the 
channel, and levels 1,2, and 3 correspond to conductance values of 57,120, and 184 pS, respectively. From the 
current-amplitude histogram, it seems that the three detected levels could represent the insertion of simulta­
neous channels (level 1, one channel; level2, two channels; level 3, three channels).
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of 1.2 and 1.5 S at 2.0 and 0.33 mg/ml C12E8 are consistent with 
globular compact assemblies of 5-6 and 6-7 solvated p7 
monomers, on average. Equilibrium sedimentation experi­
ments (see supplemental Table S2) allowed us to determine a 
mean association state of 6 ± 1 subunits for p7 in the presence 
of 2 mg/ml C12E8. However, here again, the association state 
increased when detergent concentration was decreased. In 
addition, the mean association increased with time, and exper­
iments at the highest angular velocity revealed sample 
heterogeneity.
Put together, these data are consistent with the hexamer and 
heptamer of p7 reported by others (20, 23, 24) but highlight an 
intrinsic heterogeneity of p7 modulated by the C12E8 detergent 
concentration. They maybe further indicative of a possible nat­
ural polymorphism of the p7 oligomeric state. This relative p7 
oligomer heterogeneity could, nevertheless, explain the failure 
of crystallization assays.10
10 E. Pebay-Peyroula and D. Cannella, personal communication.
Conformation Analyses of p7 by 
CD—As expected from its hydro- 
phobic nature, p7 is not soluble in 
water, and its secondary structure 
was therefore examined by CD 
spectroscopy after solubilization in 
the presence of either lysophos- 
phatidylcholine micelles (LPC), or 
various detergent micelles (DPC 
and SDS), or cosolvents (TFE-water 
mixture; TFE 50%) that mimic the 
membrane environment (Fig. 3). 
These membrane mimetics were 
selected to reflect the various condi­
tions in a true membrane, in order 
to gain a more comprehensive pic­
ture of the p7 structure. The CD 
spectra of p7 recorded in these 
membrane mimetics exhibited sim­
ilar shapes and were typical of 
a-helical folding, with two large 
minima around 208 and 222 nm and 
a maximum around 192 nm. The 
various CD deconvolution methods 
employed indicate a predominant 
a-helix content ranging from 59 to 
68% in lysophosphatidylcholine 
micelles, detergents, and 50% TFE. 
Increasing the TFE concentration 
above 50% resulted in only minor 
changes in the amplitude of the 
spectrum (data not shown), show­
ing that the maximum a-helical 
folding is reached in 50% TFE. The 
higher a-helix content observed in 
TFE when compared with deter­
gents or lysolipids could be due to 
the monomeric state of p7 in TFE, 
whereas it is expected to form olig­
omers in detergent micelles, as shown above in C12E8. In addi­
tion, TFE is known to stabilize the folding of peptidic sequences 
exhibiting an intrinsic propensity to adopt an a-helical 
structure, but such folding could be different from the native 
one, in particular in oligomeric structures (for an overview 
about TFE, see Refs. 56 and 57). CD spectral analyses indi­
cated, nevertheless, that p7 mainly adopts an a-helical struc­
ture in lipid environment and show that 50% TFE is an 
appropriate medium to mimic the membrane-like environ­
ment of p7. These results validate its use to probe the sec­
ondary structure of p7 by NMR.
NMR Analyses ofp7 Peptide—Preliminary NMR spectra of 
p7 dissolved in deuterated detergents (DPC and SDS) showed 
broad NMR signals due to the large size of the peptide-deter­
gent micelle and the expected oligomerization of p7 (data not 
shown). Such a complex could not be analyzed by proton NMR 
and would require at least the preparation of recombinant 15N- 
and 13C-labeled p7. In contrast, well resolved proton and natu­
ral abundance 13C NMR spectra were obtained from p7 dis-
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FIGURE 3. Far-UV CD analyses of p7 in various membrane mimetic envi­
ronments. CD spectra were recorded in 5 mM sodium phosphate buffer, pH 
7.5, complemented with either 1% L-a-lysophosphatidylcholine [LPC; small 
dashed line}, 100 mM SDS [dotted line}, 100 mM DPC [large dashed line}, or 50% 
TFE [solid line}.
solved in 50% TFE, as illustrated by the extracts reported in 
supplemental Fig. S3.
The limited chemical shift dispersion of p7 amide protons is 
typical of all a membrane proteins. Amide backbone reso­
nances of the N-terminal half of p7 (Leu2-Val37) range less than 
2 ppm, whereas those of the C-terminal half (Gly39-Ala63) 
range less than 0.8 ppm, overlapping the previous amide reso­
nances. Additional assignment difficulties were due to the six 
consecutive leucine residues in the C-terminal half of p7 
(Leu50-Leu55). Despite limited dispersion and overlapping of 
amide cross-peaks, all 58 backbone amide resonances of p7 
could be assigned. The additional resolution gained with 13C 
natural abundance HSQC and HSQC-TOCSY experiments 
permitted the determination of all xHa resonances dispersed in 
a range of only 1 ppm. Finally, it was possible to assign all of the 
backbone xHa and X3Ca and most side chain XH and l3C reso­
nances. The four proline residues were identified based on their 
particular XH3 and 13C8 chemical shifts and were confirmed to 
be in trans based on the X3C chemical shift analysis performed 
with the Promega software (Shin Y and Bay A). In addition, 
Pro38 and Pro49 also exhibit short NOE contacts between 
3-CH2 Pro and the spin system of the preceding residue. NMR 
analyses of the p7(35— 63) peptide in the same conditions con­
firmed and completed the resonance assignments for the C-ter­
minal p7 half and allowed us to gain information about the 
structure of this region (see below). The XH and X3C chemical 
shift of p7 and p7(35— 63) are available at the BMRB data bank 
under the accession numbers 6087 and 15951, respectively.
Overviews of the sequential and medium range NOE con­
nectivities for the full-length p7 and p7(35—63) peptides are 
shown in Fig. 4, A and B, respectively. The N-terminal half 1-36 
of p7 displays most of the characteristics of an a-helix confor­
mation with strong dNN(z, i + 1) and medium daN(z, i + 1) 
sequential connectivities, weak daN(z, i + 2), medium 
daN(z, i + 3), medium or strong daj3(z, i + 3), and weak 
daN(z, i + 4) medium range connectivities. In the remaining 
sequence, hatched by proline residues, similar medium range 
NOE contacts show the presence of an a-helical folding 
between Gly39 and Leu57. The C-terminal end of the protein 
(Pro58-Ala63) is empty of medium range NOEs and remains 
unstructured.
The NOE-based indications of secondary structural ele­
ments are supported by the deviation of the xHa and X3Ca 
chemical shifts from random coil values reported in Fig. 4C 
(chemical shift index) (58). The long series of negative variation 
of xHa chemical shifts (A3xHa <0.1 ppm) as well as the posi­
tive variation of X3Ca chemical shifts (A8l3Ca > 0.7 ppm) 
observed for residue stretches 2-14, 20 -34, 38 - 46, and 49 -55 
are, indeed, typical for an a-helical conformation. The weaker 
negative A3xHa values observed for Gly15, Gly19, and Leu19 
indicate the presence of some helical folding, but the absence of 
a clear continuous negative pattern suggests some flexibility in 
this region. The positive A3xHa and weakly positive A8X3Ca 
values for Leu36-Val37 are consistent with the absence of helical 
folding, and the similar chemical shift pattern observed for 
Val47-Trp48 is indicative of some discrepancy of the helix struc­
ture due to the presence of a proline residue at position 49. The 
A3xHa and A8X3Ca values in the C-terminal segment 56-63 
are in keeping with the absence of regular structure in this 
region.
Put together, these results suggest that p7 protein consists of 
two distinct structural regions separated by an unstructured 
segment at the level of Gly34-Pro38: an ordered a-helical N-ter­
minal region 1-34 with a flexible zone at the level of residues 
Gly15 and Gly18 and a C-terminal mostly helical region flanked 
by a flexible C terminus. Based on the NOE-derived interproton 
distance constraints, sets of structures were calculated with 
X-PLOR, and low energy structures that fully satisfied the 
experimental NMR data were retained (see “Experimental Pro­
cedures”). Concerning the N-terminal half of p7, two sets of 
structures were calculated corresponding to segments 1-18 
and 18-39. Indeed, the overall structure of the 1-39 segment 
could not be calculated as one piece due to the lack of unam­
biguous distance restraints in the connecting segment 15-19. It 
should be noted that any attempt to fix this connecting segment 
15-19 as an a-helix in structural calculations failed to yield 
structures satisfying the experimental NMR data, thus illumi­
nating particular structural features for this segment. The 
C-terminal half of the p7 structure was calculated using 
the distance restraints obtained with the p7(35— 63) peptide. 
The number and types of NOE constraints used for p7(35- 63) 
structure calculations of p7(35—63) as well as the statistics for 
the final set of 30 structures are given in supplemental Table S3. 
The representative structure models of p7 segments are shown 
in Fig. 4£.
TFE was a very useful tool for probing the secondary struc­
ture preference of p7 and p7(35 — 63) and to stabilize the a-helix 
folding of segments exhibiting such a propensity, but a major 
concern is the relevance of the stabilized structure elements to 
their native conformation (56), in particular for p7 when olig­
omerized. Moreover, TFE is known to disrupt the hydrophobic
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FIGURE 4. NMR analysis and structure calculation of p7 in TFE 50%. A and B, summary of sequential (/, / + 1) and medium range (/, / + 2 to i + 4) NOEsfor 
full-length p7 and p7(35-63) peptides, respectively. Intensities of NOEs are indicated by bar thickness; asterisks indicate that the presence of a NOE is not 
confirmed because of resonance overlap. C, chemical shift differences for ’Ha and 13Ca at each position. These differences were calculated by subtraction of 
the experimental values from the random coil conformation values (43, 44). A comparison of chemical shift differences observed for segment 35-63 of 
full-length p7 and p7(35-63) peptides is available in supplemental Fig. S3. D, secondary structure elements deduced from the NMR data. The boxes indicate the 
helical elements. The gray boxes highlight some particular features within the helical elements (see "Results"). E, ribbon representations of NMR average 
calculated structures of p7 segments 1-18 (left), 18 -39 (medium}, and of p7(35-63) (right) (see "Results" for details). Ca-C/3 bonds of the polar residues (Thr, Ser, 
Glu, Asn, Lys, and Arg) are represented. The aromatic side chains of Phe, Tyr, and Trp as well as the cyclic side chains of Pro and His are displayed. The polar 
residues, including Gly, are colored light gray, and the other residues are dark gray.
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FIGURE 5. Model of the monomeric p7 protein inserted in a fully hydrated POPC bilayer. A, representative 
snapshot of the p7 peptide in the POPC bilayer during MD simulation. The protein backbone structure is 
depicted in a ribbon and tube representation. Purple ribbons denote a-helices, whereas cyan tubes correspond to 
turns. Random coils are shown as light gray tubes. The model lipid membrane is described by means of a 
semitransparent space-filling representation of POPC molecules, with the phosphorus atoms displayed as glossy 
orange van der Waals spheres. The positively charged Lys33, Arg35, and Arg60 residues interacting with the 
headgroup region of the lipid bilayer are highlighted in a blue, semitransparent representation. Water molecules 
are represented as light blue van der Waals spheres. Right top inset, dose up of the TM1-TM2 interaction, whereby 
a double iT-iTStacking contributes to the overall stability of the a-helix bundle. Right bottom inset, interaction 
of the positively charged Lys33 and Arg35 residues located at the tip of the hairpin with the headgroup re­
gion of the POPC lipids. B, evolution of the secondary structure of p7 as a function of time. The secondary 
structure of the protein was determined with the STRIDE program (59). Color coding is as in A. Nter helix, 
N-terminal helix; Cter coil, C-terminal coil segment. C, density profiles for the different components of the 
molecular assembly depicted in A, determined from an average over the last 10 ns of the simulation. 
D, Jacobian corrected probability distribution of the angle <p formed by the longitudinal axis of either TM1,TM2, 
the N-terminal a-helix, or the C-terminal random coil and the normal to the water-membrane interface. Inset, 
probability distribution of the angle formed by the contiguous TM1-TM2 and N-terminal a-helix-TM1 seg­
ments. All image rendering in this figure was performed with the VMD program (49). The atomic coordinates 
for the representative p7 model in POPC bilayer during MD simulation is available at the IBCP website.
interactions involved in the three-dimensional structure fold 
and imperfectly mimic the phospholipid environment. To 
overcome these limitations, the reconstruction of the three- 
dimensional structure of the p7 monomer was done by molec­
ular modeling and numerical simulation in a POPC membrane 
model by molecular dynamics.
Molecular Modeling and Molecu­
lar Dynamics Simulations of the p7 
Monomer in a Fully HydratedPOPC 
Phospholipid Bilayer—'The model 
of the complete p7 monomeric pro­
tein was built on the basis of the 
structural information acquired 
from CD and NMR experiments in 
membrane mimetics (this study) 
and the p7 membrane topology 
with both N and C termini point­
ing toward the endoplasmic retic­
ulum lumen, as determined previ­
ously (8) (see “Experimental 
Procedures”). The relevance of 
this model in a membrane envi­
ronment was appraised by molec­
ular dynamics simulations of the 
monomeric p7 protein immersed 
in a fully hydrated POPC lipid 
bilayer (Fig. 5). Analysis of the 
molecular dynamics trajectory illu­
minates the remarkable stability of 
the p7 protein in its membrane 
environment (Fig. 5B). As can be 
seen in this panel, only marginal 
fluctuations in the secondary struc­
ture are witnessed in the course of 
the simulation (59). The core of the 
three helical segments is completely 
preserved, with merely transient 
fraying at the tail end of the N-ter­
minal a-helix. The hairpin motif 
formed by TM1 and TM2 spans the 
hydrophobic core of the POPC lipid 
bilayer, whereas N-terminal helix 
and C-terminal random coil mainly 
lie at the membrane interface (Fig. 5, 
A and C). Roughly speaking, the 
boundaries between TM1 and the 
N-terminal a-helix as well as 
between TM2 and the C-terminal 
random coil emerge at the level of 
the ester functional groups of the 
lipid units. The small loop that con­
stitutes the tip of the hairpin 
extends toward the headgroup 
region of the opposite leaflet, the 
positively charged residues of the 
former (i.e. Lys33 and Arg35) inter­
acting directly with the phosphate 
moieties of the latter (Fig. 5A). It is 
noteworthy that TM1 and TM2 remain anti-parallel through­
out the entire run, their respective longitudinal axes being 
essentially collinear with the normal to the water-membrane 
interface. The probability distribution of the angle formed by 
the principal axis of each a-helix and the normal to the surface 
of the lipid bilayer is particularly sharp, peaking at 14° for TM1
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and 5° for TM2 (Fig. 5/1). These helix tilt angles are comparable 
with the —10 and 25° tilts reported recently for recombinant p7 
reconstituted in phospholipid and studied by solid state NMR 
(16). In contrast, the angular distribution for the N-terminal 
a-helix is diffuse, which is reflected in the propensity of the 
helical segment to tilt by up to 25° about the turn formed by 
residues Gly18 and Leu19. This increased flexibility in the pro­
tein chain is further magnified at its C terminus, the random 
coil exhibiting a marked tendency to slant with respect to the 
TM orientation without any significant energetic penalty. To a 
large extent, stability of the monomeric p7 protein in the mem­
brane environment can be explained in terms of a subtle bal­
ance of protein-protein and protein-lipid interactions. As has 
been mentioned previously, long lived interactions of the lipid 
units with the positively charged amino acids, either pertaining 
to the small loop domain or the C-terminal random coil, have 
been monitored. These interactions, illustrated in Fig. 5A, can 
be viewed as molecular anchors of the protein in the lipid 
bilayer. One possible reason for the remarkably steady anti­
parallel arrangement of TM1 and TM2 lies in the strength of 
the participating interhelical contacts. Of particular interest, as 
highlighted in Fig. 5A, the hairpin motif features a double tt-tt 
interaction formed by three stacked aromatic residues (z.e. 
Phe26, Tyr45, and Trp30) (see supplemental Fig. S4). Displace­
ment of the Ti-electron clouds with respect to each other dimin­
ishes the repulsive quadrupole-quadrupole interaction while 
increasing the attraction through dispersive forces. On the 
basis of a model of phenylalanine, a tt-tt interaction consisting 
of two optimally stacked aromatic rings has been shown to 
amount to about —3.4 kcal/mol (60). This tt-tt interaction is 
expected to be reinforced in the case of tryptophan, as a result of 
an increased dispersion contribution. In addition, cooperative 
effects are envisioned to tighten even further the interaction of 
the two TM a-helical segments. Interestingly enough, these 
tt-tt interactions were clearly absent in the original model 
because rigid body protein-protein docking precludes the 
interdigitation of the side chains to be optimized. The latter 
occurred at the stage of the molecular dynamics simulation, 
rapidly yielding an array of stacked aromatic amino acids, stable 
over the multinanosecond time scale.
Essential Structural Elements ofp7—To highlight better the 
essential structural features of p7, the p7 monomer structural 
model was analyzed concomitantly with amino acid conserva­
tion or variability in any genotype at a given sequence position. 
We performed an exhaustive analysis of the p7 sequence varia­
bility based on the 1325 full-length p7 sequences of various 
genotypes reported to date in the public databases and docu­
mented in euHCVdb (3).
The amino acid repertoires derived from the multiple align­
ments revealed that, whereas the intragenotype amino acid var­
iability is limited (61) (data not shown), the intergenotype var­
iability is rather important at most sequence positions. This is 
illustrated in Fig. 6A, showing the sequence alignment of refer­
ence sequences representative of all major genotypes and sub­
types (2). Besides the highly conserved dibasic motif bGb 33-35 
in the cytosolic loop, only nine invariant amino acids emerged 
(labeled by an asterisk in the similarity pattern), thereby under­
lining their essential role for the structure and/or function of 
p7. The apparent variability at most other positions is, however, 
limited because the observed residues exhibit similar physico­
chemical properties, as indicated both by the similarity pattern 
(Fig. 6A, colons and dots') and the hydropathic pattern, where 
the letters o, i, and n denote hydrophobic, hydrophilic, and neu­
tral residues, respectively (see the legend to Fig. 6A for details). 
Hence, despite this apparent variability, the conservation of the 
hydropathic character at most positions (highlighted in gray 
and yellow for hydrophobic and hydrophilic positions, respec­
tively) indicates that the overall structure of p7 is conserved 
among the various HCV genotypes.
NMR and MD structural analyses of synthetic p7 allowed 
three a-helical segments to be identified, namely the N-termi­
nal helix 2-14, the TM1 helix 19-32, and the TM2 helix 40 -56 
(Fig. 6B). The N-terminal helix is connected to the TM1 helix 
by a turn (15-18), and TM1 is connected to TM2 by a small loop 
(33-39), including the dibasic motif. The C terminus region of 
p7 (57- 63) appears to be unstructured. TFE used here to mimic 
the membrane hydrophobic core is recognized to stabilize 
a-helical structures only in peptides or protein regions that 
have an inherent helical propensity (56).
The N-terminal helix observed in TFE and its stability in MD 
simulations in POPC clearly indicate that this helix should be 
folded at the level of the membrane interface and/or in p7 inter­
actions with viral or cell factors. The physicochemical proper­
ties of this helix appear to be very well conserved among the 
various HCV genotypes (Fig. GA), and its relatively hydrophilic 
nature is consistent with its location at the membrane interface 
(Figs. 5 and 6, C andD).
The 15-18 turn is mainly composed of small hydrophilic 
residues and includes residue Gly18, which is fully conserved in 
any genotype. The quite well conserved physicochemical prop­
erties of residues 15-18 indicate that this turn is present in the 
p7 structure, irrespective of the genotype. Moreover, the pres­
ence of residue 17 (here His17), which has been identified as one 
of the residues lining the pore in p7 oligomers (28), indicates 
that this turn is an essential structural determinant for p7 func­
tion. From a structural point of view, this turn probably consti­
tutes a flexible link between the rigid N-terminal and TM1 
helices.
Despite its apparent variability, the physicochemical proper­
ties of TM1 transmembrane helix 19-32 are rather well con­
served. This helix is expected to bear the p7 pore-lining resi­
dues (see below).
The cytosolic loop 33-39 at the membrane interface con­
tains the fully conserved dibasic motif shown to be crucial for 
infectivity in vivo as well as ion channel activity and function of 
the protein in virus release (7,10,11,15). The conserved hydro- 
phobic nature of segment 36-39 is consistent with its location 
at the hydrophilic-hydrophobic membrane interface (Figs. 5 
and 6, C and D). This loop, which is longer than expected from 
secondary structure predictions, could confer a large flexibility 
between the TM1 and TM2 helices, allowing their relative 
reorientation, which may occur upon p7 oligomerization.
The TM2 transmembrane helix appears to be slightly bent on 
account of the presence of residues Pro49 and Gly46. The full 
conservation of Pro49 in all genotypes (except for some geno­
type 2 subtypes and genotype 3a) on one hand and of Gly46 in all
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FIGURE 6. Variability of p7 and tentative model of p7 ion channel. A, multiple alignments of p7 sequences from representative HCV strains of confirmed 
genotypes (listed in Table 1 in Ref. 2). Genotype, accession number, and strain are indicated for each sequence. Amino acids are numbered with respect to p7, 
and the polyprotein of HCV strain H77 was used as a reference (77) (top row). The consensus sequence (top row) was deduced from the ClustalW multiple 
alignment of the indicated p7 sequences (30). To highlight the amino acids variability at each position, amino acids identical to the consensus sequence are 
indicated by hyphens. The degree of amino acid physicochemical conservation at each position can be inferred with the similarity index according to ClustalW 
convention (asterisk, invariant; colon, highly similar; dot, similar) (30) and the consensus hydropathic pattern: o, hydrophobic position (Phe, lle,Trp,Tyr, Leu, Vai, 
Met, Pro,Cys);n,neutral position (Gly, Ala,Thr, Ser);/, hydrophilic position (Lys,Gin, Asn, His,Glu, Asp, Arg);£>, basic position; v, variable position (i.e. when both 
hydrophobic and hydrophilic residues are observed ata given position); strictly conserved amino acids in all genotypes are indicated with their one-letter code. 
To high light the variable sequence positions in p7, conserved hydrophilic and hydrophobic positions are high lighted in yellow and gray, respectively. Polar and 
positively and negatively charged residues are color-coded in orange, blue, and red, respectively. Cysteine residues are in green, and all other residues are in 
black. Amino acids of the p7 sequence used in this study (1b mutC27A HCV-J, bottom raw) are colored accordingly, except for Trp and Tyr, which are colored 
magenta and purple, respectively, according to the p7 structure representation shown in C (see below). B, schematic representation of helical, turn, and loop 
regions deduced from the NMR structure analysis (see Fig. 4). C, side v/ewof the p7 representative monomer structure in the POPC bilayer showing the putative 
helix side and residues facing the ion channel. The corresponding p7 amino acid sequence is shown in A (HCV-J strain). The structure backbone is represented 
as a ribbon, and only some amino acid side chains are shown, including residues likely to be involved in interhelix interactions, residues expected to be oriented 
toward the ion channel (boxed labels), basic residues of the cytosolic loop, and some residues to provide a visual reference for the orientation of p7. Yellow, Ser, 
Thr,and Asn; green, Cys; cyan, His; b/(/e, Argand Lys; red, Giu; magenta,Trp; purple,Tyr; black, Pro; gray, any other residues. The polar head sand hydrophobic tails 
of phospholipids (thin stick structures) are light gray and orange, respectively. D, tentative representation of p7 monomer within a putative ion channel 
oligomer. A180° rotation is applied between the two structures. Images in CandD were generated from structure coordinated using the VMD program (49) and 
rendered with POV-Ray.
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genotypes (except some genotype 6 subtypes, d, g, h, and k) on 
the other indicates that this bending is a specific feature of 
TM2. A markedly reduced channel activity was reported for 
recombinant P49A mutant in a liposome assay (26), which 
could be due to a role of TM2 bending in p7 oligomerization or 
other intermolecular interactions. Remarkably, the TM2 helix 
includes three fully conserved residues in all genotypes (z.e. 
Tyr42, Trp48, and Leu52). The full conservation of Tyr42 in TM2 
together with that of Trp30 in TM1 is consistent with their 
interaction through aromatic ring stacking, which contrib­
utes to the overall stability of the helix TM1-TM2 bundle in 
p7 monomer. In contrast, the fully conserved aromatic resi­
due Trp48 does not appear to be involved in the interaction of 
the two TM a-helical segments. Its relatively external posi­
tion in TM2 suggests that it could play an essential role in the 
intermolecular binding of p7 units in the oligomeric state. 
Leu52 belongs to the helical leucine-rich region 50-55 and 
appears to be close to Phe22 in TM1 of our p7 monomer 
model, suggesting some stabilization of the helix TM1-TM2 
bundle through hydrophobic interactions. Such an interac­
tion is, however, questionable because Phe at position 22 is 
poorly conserved in all genotypes. Interestingly enough, the 
recombinant L(50-55)A mutant was shown to retain wild­
type ion channel activity in a liposome assay (26), thereby 
indicating that the leucine-rich region is not essential for p7 
oligomer stabilization and ion channel activity. This region 
is in fact more likely to be involved in intermolecular inter­
actions with other viral and/or cellular factors.
Although the C-terminal region of p7 (57-63) appears to be 
unstructured, it includes the three fully conserved residues 
Pro58, Ala61, and Ala63. This conservation may be linked to the 
conformational changes required for the cleavage of the 
p7-NS2 junction by a signal peptidase (6, 8). It is noteworthy 
that high-resolution magic angle spinning NMR experiments of 
p7 in deuterated DPC micelles revealed some well resolved sig­
nals corresponding to residues outside the detergent micelle 
(data not shown). Some of them were clearly identified as ala­
nine residues and probably correspond to Ala61 and Ala63, as 
assigned by comparison with liquid state chemical shifts. This 
finding supports the location of segment 61-63 outside the 
POPC membrane in the MD p7 model (Figs. 5 and 6, C and D). 
Moreover, because p7 is expected to form oligomers in DPC 
micelles, this indicates that segment 61-63 would be accessible 
also in p7 oligomers. Put together, these findings suggest that 
the well conserved polar segment 59-63 (QPRAYA here) could 
also play a particular role in p7 intermolecular interactions with 
other viral and/or cellular factors.
Putative p7 Pore-lining Residues—The structural elements 
of p7 essential for its ion channel activity are not yet clearly 
established. However, there is a growing body of evidence 
pointing to the essential role of the N-terminal half of p7. 
Indeed, synthetic peptides corresponding to this region dis­
play ion channel-like properties (27) (this study). Moreover, 
point mutation analysis using recombinant p7 from strain J4 
(genotype lb) identified amino acids that are important for 
channel function in a liposome assay (26). Whereas muta­
tions S21A or C27A had no effect on channel activity, H17A 
mutation caused a decrease in p7 channel activity. In con­
trast, a synthetic p7 from strain H77 (genotype la), including 
the H17A mutation, was shown to exhibit wild-type ion 
channel activity when reconstituted in a planar lipid bilayer 
(28). However, this His17 was shown to be involved in Cu2 - 
mediated inhibition of channel activity of synthetic p7 from 
both H77 and JFH-1 strains, indicating that this His17 resi­
due lines the p7 channel lumen (28). The presence of a 
hydrophilic serine or aromatic residue tryptophan or tyro­
sine in the next helix turn at position 21 (here a serine; Fig. 
6C) suggests that this residue also faces the pore, albeit 
mutation S21A had no effect on channel activity (26), and 
proline or cysteine can also be observed at this position (Fig. 
6A). Because the downstream helix residues facing the pore 
are expected to be on the same side of the TM1 helix (Fig. 
6C), residues at positions 24 or 25 and 27 or 28 in the two 
next helix turns constitute pore-lining candidates (see 
below). Finally, because position 31 is often occupied either 
by a hydrophilic residue histidine or aromatic residue tyro­
sine bearing a polar hydroxyl group in the various HCV gen­
otypes, residue 31 is expected to face the pore. Although 
determination of the high resolution structure of the oligo­
meric form of p7 will be required to specify the pore-lining 
residues, a tentative representation of a single p7 unit within 
a putative ion channel oligomer may be proposed as a work­
ing model (Fig. 6D). It should be noted that no attempt has 
been made here to fit this representation to the corolla-like 
EM hexameric structure, in which the protruding petals cor­
respond to the subunits (23). One can suppose, however, that 
the p7 monomers should be tilted relative to the membrane 
bilayer to fit this corolla-like structure, possibly in conjunc­
tion with the kinking of the N- and C-terminal p7 structural 
elements.
As demonstrated in this study, alanine mutation of the can­
didate pore-lining residue Cys27 did not affect p7 channel 
activity in vitro. This is consistent with the slight reduction of 
activity of recombinant C27A p7 mutant from strain J4 in a 
cell-based hemadsorption surrogate assay (15). This Cys27 res­
idue is conserved in all genotypes but genotype 2 (Fig. 6A). 
Interestingly enough, whereas hydrophobic residues valine and 
isoleucine instead of cysteine are observed at position 27 in 
subtypes a, c, and k of genotype 2, a cysteine residue is observed 
in the TM1 helix at position 16 (2a), 21 (2k), or 31 (2c) (z.e. at or 
close to a pore-lining residue candidate). The only subtype for 
which no cysteine residue was observed in p7 TM1 is 2b, but the 
polar residue threonine is present at position 27 in this subtype. 
It should be noted that in addition to residue Cys27, additional 
cysteine residues are observed in TM1 for p7 of all subtypes of 
genotype 6 (except in 6k) at or close to pore-lining residue can­
didates. These observations indicate that a cysteine at or close 
to a pore-lining residue candidate is of importance for func­
tional p7. The implication of Cys27 as a pore-lining residue is, 
however, enigmatic. Indeed, it is difficult to imagine that the 
probable clustering of 6 -7 cysteine residues forming a ring of 
SH groups within the p7 oligomeric pore would be chemically 
neutral because disulfide bond formation could occur and 
would probably block the channel functioning. Alternatively, 
this cysteine residue might be involved in the conformational 
changes expected to occur upon p7 oligomer assembly and/or 
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in some interaction with other viral or cell factors. Finally, cys­
teine residues are quite commonly observed in the p7 TM2 
helix of various genotypes, including 2a, 2c, 4a, 5a, 6a, 6b, and 
7a. Such a high frequency of cysteine residues in p7 transmem­
brane segments strongly suggests the involvement of some 
redox mechanism in structure and/or function of p7 (e.g. pos­
sibly some reversible association between p7 monomers or to 
other viral or cell factors by disulfide-bond formation and 
release).
DISCUSSION
In this report, we investigated the ion channel properties and 
the detailed structure of a chemically synthesized p7 from 
HCV-J strain (genotype lb). The ion channel activity of p7 
C27A reconstituted in artificial lipid membranes is comparable 
with that reported by others (18,19, 21, 28) but is shown to be 
resistant to amantadine inhibitor. A polymorphism of p7 oligo­
meric state with a mean association of 6 ± 1 subunits in C12E8 
detergents was observed by analytical centrifugation, thereby 
supporting the existence of both hexameric and heptameric 
oligomerization of p7. Detailed structural analyses of p7 by 
NMR revealed significant differences with secondary structure 
predictions. MD simulations in phospholipids allowed us to 
propose a three-dimensional model of the p7 monomer, which, 
at least transiently, exists during HCV polyprotein biosynthesis 
and processing. Our studies identified structural distinctive­
ness elements that are conserved among HCV genotypes and 
probably constitute essential determinants for p7 assembly and 
function.
The p7 C27A polypeptide that we have synthesized for this 
study was found to form ion channels in lipid bilayers. Because 
this polypeptide was prepared chemically with a high degree of 
purity and without any fusion partner proteins or tags, the pos­
sibility that the channel activity might have been caused by a 
molecule other than p7 is unlikely. It was, therefore, concluded 
that Cys27, conserved in p7 sequence representative of the prin­
cipal HCV subtypes, was not required for a functional channel. 
The channel activity that we observed is not perfectly identical 
to those reported in previous p7 channel studies. This could be 
due to the fact that p7 proteins from different genotypes have 
been studied and/or that C27A substitution may induce some 
changes in the p7 structure and, consequently, on its channel 
properties.
The presence of a non-linearity in the p7 current-voltage 
curves, a characteristic also observed recently for the Vpu pro­
tein, a viroporin from HIV-1 (62), and for channel-forming 
peptides, such as alamethicin (63) and ceratotoxin (64), is an 
indicator of a voltage-dependent component to channel for­
mation. In light of selectivity measurements, p7 channels 
were found to be more permeable to cations than to anions 
with a PK+/PC1- ratio of about 11. Cation selectivity is a char­
acteristic reported for other ion channels encoded by small 
virus proteins belonging to the viroporin family, such as M2, 
NB, Vpr, Vpu, and alphavirus 6I< proteins (17). In a compu­
tational approach, the cation selectivity of Vpu was attrib­
uted to a ring of serine residues pointing toward the interior 
of the pore (65). In our p7 C27A, the serine amino acid at 
position 24 belongs to the list of putative residues lining the 
ion-conducting pore. It is, however, difficult to understand 
how this sole amino acid could be responsible for the strong 
cation selectivity that was observed. It is possible that nega­
tively charged and hydrophilic residues (Glu3, Asp4, and 
Asn9) from the N-terminal helix, presumably located at the 
membrane interface, could be involved in the cation selec­
tivity measured for p7 as discussed below.
We have observed thatp7 C27A channels as well as p7(l-34) 
channels could exhibit multiple conductance levels. Typically, 
current recordings like those displayed in Fig. IB have 
revealed multiple states of current that could represent the 
insertion of simultaneous channels. However, we cannot 
exclude the possibility that some of these states could reflect 
an increase of conductance due to the association of addi­
tional transmembrane segments (z.e. p7 monomers) in the 
channel, as has been observed in a-helix bundles formed by 
the alamethicin and ceratotoxin peptides (63, 64). Such mul­
tiple conductance levels, which may correspond to different 
degrees of oligomerization of the peptide to form channels, 
have also been observed for the NB peptide of influenza B 
and Vpu (62, 66).
Inhibition of the p7 ion channel activity by HMA in our in 
vitro assay is in agreement with reported results (19). In con­
trast, we did not observe inhibition by amantadine, even at high 
concentration, whereas Griffin et al. (20) described the com­
plete blocking of the p7 ion channel by 1 /xm amantadine in 
artificial membranes. This is surprising because the sequence of 
p7 from strain HCV-J used in our study only features four 
amino acid differences with strain J4 used by Griffin et al. (20) 
(T1A, L19I, V37A, and L44F). In addition, both strains possess 
identical sequences in the C-terminal p7 region, where aman­
tadine probably interacts. A p7 L(50 -55)A mutant was, indeed, 
recently shown to exhibit resistance to amantadine (26), and 
the involvement of leucine residues 51-57 (with the exception 
of Leu53) in amantadine interaction was recently confirmed by 
NMR and also probably includes His17 (16). We cannot exclude 
the possibility that the absence of ion channel inhibition by 
amantadine for our p7 peptide might be related to the substi­
tution of Cys27 by alanine. Alternatively, the discrepancy in 
amantadine inhibition data may be due to the different p7 pro­
tein constructs that were utilized. We, indeed, used here a syn­
thetic p7 peptide, whereas Griffin et al. used recombinant 
fusion proteins GST-p7 and GST-HIS-p7 (15, 20) or GST- 
FLAG-p7 and FLAG-p7 (24), which may exhibit differences in 
their properties. In addition, the differences between proteoli- 
posome reconstitution and the lipid systems utilized could also 
have some influence because amantadine was demonstrated to 
bind preferentially in the interfacial region of the lipid bilayer 
on the basis of molecular dynamics simulations (67). This could 
explain why we observed in our measurements an increase of 
the current upon the addition of amantadine. It is possible that 
binding of amantadine to the membrane interface might stabi­
lize an open conformation of the p7 channel, hence resulting in 
larger ion fluxes.
Molecular dynamics simulations of the monomeric p7 NMR 
structural model in a POPC membrane environment not only 
appraise the relevance of the protein model but also help to 
dissect the participating protein-protein interactions and shed 
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new light on the subtle protein-lipid interplay. These coupled 
structural analyses allowed three a-helical segments to be iden­
tified, namely the N-terminal helix (residues 2-14), the TM1 
helix (residues 19-32), and the bent TM2 helix (residues 
40-56). The N-terminal helixis connected to the TM1 helix by 
a turn (residues 15-18), and TM1 is connected to TM2 by a 
small loop (residues 33-39), including the dibasic motif. The 
C terminus region of p7 (residues 57-63) appears to be 
unstructured.
Some elements of this structural organization differ substan­
tially from predicted secondary structures used for the molec­
ular modeling of p7 monomer and oligomers (8, 24-26). 
Indeed, neither the N-terminal helix nor the turn was pre­
dicted, the cytosolic loop is longer, and the TM2 helix ends at 
residue 56.
The turn between the N-terminal and TM1 helices is a major 
finding, which is reminiscent of the kink at lie17 found in the 
Vpu transmembrane helix and identified as a structural deter­
minant of Vpu ion channel activity (68,69). The presence of the 
pore-lining residue 17 (28) in this p7 turn indicates that it con­
stitutes an essential structural determinant for p7 ion channel 
functioning. This turn probably constitutes a flexible link 
between the rigid N-terminal and TM1 helices that can be con­
sidered as the two distinct components of a single transmem­
brane helix kinked by the 15-18 turn. This conserved flexibility 
in any genotype suggests the existence of some rigid body 
movements of a-helices, which are expected to occur upon p7 
assembly and/or p7 pore opening and closing.
Another interesting finding is the larger length of the cyto­
solic loop bearing the essential dibasic motif. Such a loop could 
allow TM1 and TM2 to reorient relative to each other, which 
might be triggered by p7 oligomerization and/or ion channel 
function, as has been proposed above. The conserved bending 
of the TM2 helix could also play an essential role in these struc­
tural changes. Furthermore, TM2 is likely to be involved in the 
interaction of p7 with other viral or cell factors. This interaction 
is also expected for the highly conserved unstructured p7 C 
terminus, which, in all likelihood, is accessible at the membrane 
surface.
The physicochemical properties of the N-terminal helix 
appear to be well conserved in any genotype. Its role is presently 
unclear, but, by analogy with Vpu cytoplasmic helices, it could 
be involved in the regulation of the lifetime of the p7 channel in 
its conductive state (70) and/or cation selectivity.
The p7 ion channel has been reported to be activated by low 
pH (71), and, by analogy to the pH-dependent M2 proton chan­
nel of influenza virus, His17 has been suggested to play the role 
of pH sensor (26, 71). However, in contrast to the M2 channel, 
which only permits proton conductance, p7 is permeable to 
sodium and potassium (19) (this study). It was reported recently 
that p7 from genotypes 3-5 encodes a H2QQC(Y/W) motif 
(position 17-21) (72). This motif is reminiscent of the H2QQCW 
motif found in the influenza M2 ion channel, where the opening 
is induced by the pro to nation of the His27 imidazole ring at low 
pH, which in turn promotes an electrostatic interaction that 
results in the rotation of the indole ring of Trp41 (73). Investi­
gation of the putative role of His17 in p7 by reverse genetics, 
however, only showed slight effect on JFH1 infectivity (72). 
Although these data suggest that the presence of a histidine or 
an alternative amino acid like glutamic acid, which is proto­
nated at low pH, is important for the optimal function of p7, 
such pH sensor residues do not appear to be essential for HCV 
replication. In addition, His17 is not conserved among HCV 
genotypes because Asn, Gin, or Ala is frequently observed at 
this position (see Fig. GA). Moreover, the mutation of His17 to 
Ala in the context of synthetic p7 of strain H77 reconstituted 
into planar lipid bilayer was shown to exhibit wild-type channel 
activity (28). The presence of a histidine residue at position 17 
is, therefore, not required for ion channel activity, but the pres­
ence of a polar or neutral residue at this position appears to be 
mandatory.
Interestingly enough, a histidine residue is observed at posi­
tion 31 of p7 in various genotypes (Fig. 6A), whereas the most 
frequently observed residue at this position protruding into the 
putative ion channel lumen is a tyrosine. One might wonder 
whether this histidine residue, when present, could play a pH 
sensor role in the opening of the p7 channel. In fact, the muta­
tion of His31 to Tyrin the context of JFH1 moderately increased 
assembly, release, and infectivity of JFH1 virus particles (14). 
Moreover, the reverse mutation, Y31H, in the context of the 
Jcl chimera (z.e. including p7 of the J6 strain) did not signif­
icantly affect infectious particle production. Finally, the 
non-natural mutations H31F and H31L did not significantly 
affect virus particle production (7). Although these data 
imply that the side chain of amino acid 31 modulates the 
efficiency of p7-dependent virus production, they do not 
support a role of a pH sensor for this residue. It should be 
noted that the p7 sequences of several genotypes (2a, 2b, 2c, 
6a, 6d, and 6h; Fig. 6A) do not include any histidine or other 
charged residue in the first p7 transmembane helix. Put 
together, these data indicate that the opening of the p7 pore 
is likely to be pH-independent.
Intriguingly, it appears that none of the putative pore-lining 
residues studied to date by mutagenesis seems to be really 
essential for p7 ion channeling in vitro. Little attention has 
been paid, however, to residues 24 and 25. As has been men­
tioned previously, positions 24 and/or 25, expected to pro­
trude into the p7 pore, are clearly hydrophobic in any geno­
type. In the oligomeric structure of p7, the side chain of these 
residues should form a ring of hydrophobic side chains. Sim­
ilarly, position 27, predominantly occupied by a cysteine res­
idue (see “Results”), and position 28, occupied by hydropho­
bic residues in any genotype, are also expected to form a ring 
of hydrophobic side chains within the p7 pore lumen. These 
adjacent hydrophobic rings within the center of the mem­
brane channel obviously form an energetic barrier to ion 
permeation, which must be overcome to allow ions to trans­
locate. The presence of a hydrophobic ring is reminiscent of 
that observed in various ion channels like the nicotinic ace­
tylcholine receptor (74), the bacterial I< channel (75), and 
the MscL ion channel (76). In these channels, the removal of 
the hydrophobic barrier to ion permeation arises from the 
rigid body movements of a-helical segments, triggering the 
opening of the channel.
It is, therefore, tempting to draw a parallel for the gating of 
p7, which might obey a similar mechanism. Unfortunately, 
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except for the C27A mutation studied here and yielding wild­
type activity, virtually no mutation at these positions has been 
reported hitherto. It is worth noting that, whereas the F25A 
point mutation had no detectable effect, the recombinant triple 
mutant F22A/F25A/F26A of p7 from strain J4 was recently 
reported to exhibit a surprising increase of channel activity in a 
liposome assay (26). Because this triple mutation did not affect 
the ability of p7 to form oligomeric structures, it is tempting to 
propose that the reduction of hydrophobicity of residues 
around position 24 decreases the overall strength of the puta­
tive hydrophobic ring, hence facilitating the opening of the p7 
channel.
According to this gating mechanism, one can expect that a 
decrease of the hydrophobicity at positions 24 and/or 25, as well 
as 27 and/or 28, should increase the p7 ion channel activity. On 
the other hand, one can speculate that the fully conserved 
amino acids Trp30 and Tyr42, which were demonstrated to be 
key residues involved in the function of p7 (7), might play a 
major role in the movement of the helical segments that would 
be required for the opening of p7 channel. One can imagine that 
the aromatic ring stacking between Trp30 and Tyr42, which 
contributes to the overall stability of the helix TM1-TM2 bun­
dle in the p7 monomer, could be released and might participate 
in intermolecular interactions. Similar changes from intra- to 
intermolecular interaction could also be hypothesized for the 
side chains of the fully conserved Trp48 and Leu52, with the 
possible participation of other genotype-dependent residues 
(see “Results”). Concomitant movements of a-helical segments 
thus might occur, leading to major changes in the structural 
organization of the p7 channel, and related to the pore opening 
and closing.
In summary, the structural and functional studies 
reported here provide the first detailed structural analysis of 
the p7 monomer. The structural features of the N-terminal 
and TM1 helices that can be considered as the two distinct 
components of a single transmembrane helix kinked by the 
15-18 turn are likely to be determinants of the ion channel 
activity. This turn, which includes pore-lining residue 17, is 
likely to be related to the gating of the ion channel. The 
absence of an obvious conservation of specific hydrophilic 
residues lining the lumen of the p7 pore at positions 17, 21, 
27, and 31 contrasts with the fully conserved hydrophobic 
nature of residues at position 24/25, which should form a 
hydrophobic ring acting as an energetic barrier to ion per­
meation, possibly together with position 27/28. These fea­
tures, together with the full conservation of several specific 
residues involved in essential p7 structural elements, suggest 
that important movements of structured segments might be 
required for p7 channel opening and closing. The p7 mono­
mer model reported here provides an experimental template 
for further investigations of ion channel gating mechanism 
in p7 oligomers, notably by means of MD simulations in 
phospholipid bilayer. Finally, the substantial intra- and 
intergenotype variability of pore-lining hydrophilic amino 
acids means that anti-HCV drugs targeting these residues 
would rapidly induce viral resistance. The development of 
new drugs, therefore, should focus on compounds targeting 
strictly conserved residues involved in structural elements 
essential for p7 oligomerization and function and/or inter­
actions of p7 TM-helices, p7 monomers, or other viral or 
cellular proteins.
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